VOYA Investment Management
SGMO

VOYA Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

VOYA Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-53,715
Closed -$36K – 2899
2024
Q1 		$36K Buy
53,715
+16,659
+45% +$12.1K ﹤0.01% 2751
2023
Q4 		$20.1K Sell
37,056
-21,114
-36% -$9.73K ﹤0.01% 2892
2023
Q3 		$34.9K Hold
58,170
– – ﹤0.01% 2880
2023
Q2 		$75.6K Buy
58,170
+8,652
+17% +$11.8K ﹤0.01% 2857
2023
Q1 		$87.2K Hold
49,518
– – ﹤0.01% 2721
2022
Q4 		$155K Hold
49,518
– – ﹤0.01% 2642
2022
Q3 		$243K Buy
49,518
+2,960
+6% +$15.2K ﹤0.01% 2478
2022
Q2 		$193K Hold
46,558
– – ﹤0.01% 2410
2022
Q1 		$271K Hold
46,558
– – ﹤0.01% 2219
2021
Q4 		$349K Sell
46,558
-1,066
-2% -$9.26K ﹤0.01% 2215
2021
Q3 		$429K Hold
47,624
– – ﹤0.01% 2137
2021
Q2 		$570K Sell
47,624
-2,810
-6% -$31.8K ﹤0.01% 2011
2021
Q1 		$632K Buy
50,434
+143
+0.3% +$1.93K ﹤0.01% 1880
2020
Q4 		$785K Buy
50,291
+10,078
+25% +$118K ﹤0.01% 1643
2020
Q3 		$380K Hold
40,213
– – ﹤0.01% 1817
2020
Q2 		$360K Sell
40,213
-17,364
-30% -$161K ﹤0.01% 1868
2020
Q1 		$367K Buy
57,577
+1,854
+3% +$13.8K ﹤0.01% 1810
2019
Q4 		$466K Buy
55,723
+11,625
+26% +$107K ﹤0.01% 1922
2019
Q3 		$399K Hold
44,098
– – ﹤0.01% 1895
2019
Q2 		$475K Buy
44,098
+2,139
+5% +$22.7K ﹤0.01% 1820
2019
Q1 		$400K Hold
41,959
– – ﹤0.01% 1900
2018
Q4 		$482K Buy
41,959
+2,152
+5% +$26.7K ﹤0.01% 1736
2018
Q3 		$675K Hold
39,807
– – ﹤0.01% 1651
2018
Q2 		$565K Buy
39,807
+2,773
+7% +$46.1K ﹤0.01% 1743
2018
Q1 		$704K Sell
37,034
-993
-3% -$21.2K ﹤0.01% 1592
2017
Q4 		$624K Hold
38,027
– – ﹤0.01% 1708
2017
Q3 		$570K Buy
38,027
+4,218
+12% +$46.6K ﹤0.01% 1779
2017
Q2 		$298K Buy
33,809
+3,270
+11% +$21K ﹤0.01% 2171
2017
Q1 		$159K Hold
30,539
– – ﹤0.01% 2346
2016
Q4 		$93K Sell
30,539
-1,324,669
-98% -$4.82M ﹤0.01% 2464
2016
Q3 		$6.28K Buy
1,355,208
+173,325
+15% +$882K 0.01% 738
2016
Q2 		$6.84M Buy
1,181,883
+58,425
+5% +$372K 0.02% 688
2016
Q1 		$6.8M Buy
1,123,458
+14,446
+1% +$86.7K 0.02% 668
2015
Q4 		$10.1M Sell
1,109,012
-214,650
-16% -$1.65M 0.02% 548
2015
Q3 		$7.47M Buy
1,323,662
+352,909
+36% +$2.91M 0.02% 648
2015
Q2 		$10.8M Buy
970,753
+237,579
+32% +$3.06M 0.02% 554
2015
Q1 		$11.5M Buy
733,174
+141,261
+24% +$2.19M 0.03% 537
2014
Q4 		$9M Buy
591,913
+545,600
+1,178% +$6.63M 0.02% 620
2014
Q3 		$499K Hold
46,313
– – ﹤0.01% 1907
2014
Q2 		$707K Hold
46,313
– – ﹤0.01% 1731
2014
Q1 		$837K Hold
46,313
– – ﹤0.01% 1582
2013
Q4 		$643K Hold
46,313
– – ﹤0.01% 1756
2013
Q3 		$485K Hold
46,313
– – ﹤0.01% 1932
2013
Q2 		$362K Buy
+46,313
New +$404K ﹤0.01% 2100

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VOYA Investment Management's SGMO Position: Q2 2024 in Review

VOYA Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 53,715 shares — an estimated $36K sold.

VOYA Investment Management first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $11.5M in Q1 2015. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • VOYA Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 53,715 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $36K.
  • VOYA Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • VOYA Investment Management's SANGAMO THERAPEUTICS INC position peaked at $11.5M in Q1 2015.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.